Walmart talking with Humana on closer ties; acquisition possible: sources
Reuters
Published Mar 30, 2018 07:25PM ET
Walmart talking with Humana on closer ties; acquisition possible: sources
By Carl O'Donnell and Greg Roumeliotis
(Reuters) -
U.S. retailer Walmart (NYSE:WMT) Inc is in early-stage talks with health insurer Humana Inc (NYSE:HUM) about developing closer ties, with the acquisition of Humana being discussed as one possibility, people familiar with the matter said on Thursday.
Should the talks lead to a tieup, it would be the latest deal to bring together a retail chain and a health insurer in the last few months, following CVS Health (NYSE:CVS) Corp's $69 billion deal to acquire Aetna Inc (NYSE:AET) and Cigna (NYSE:CI) Corp's $54 billion deal to buy Express Scripts Holding Co.
Walmart approached Humana earlier this month and the deliberations are preliminary, two of the sources said. While the conversations have focused on new partnerships, an acquisition of Humana by Walmart is also something being discussed, the sources added.
The sources asked not to be identified because the deliberations are confidential. Humana and Walmart declined to comment.
Walmart and Humana have market capitalizations of $264 billion and $37 billion, respectively.
An acquisition of Humana would represent a significant strategic shift for Walmart, which is the world's largest retailer and has been focused on fending off Amazon.com Inc (NASDAQ:AMZN) in online shopping.
Amazon has also been looking at entering the healthcare sector. Earlier this year, Amazon, Berkshire Hathaway (NYSE:BRKa) Inc and JPMorgan Chase & Co (NYSE:JPM), said they would form a company aimed at cutting healthcare costs for their U.S. employees.
"The risks (for Walmart) of becoming entangled in the complex U.S. healthcare industry are considerable, especially at a time when Walmart is grappling with the competitive challenges of a rapidly shifting retail market," Neil Saunders, managing director of retail consultancy GlobalData Retail, wrote in a note.
"The hammering out of any agreement, which would be Walmart's largest ever corporate deal, would, of itself, be an enormous distraction," Saunders added.
Walmart currently has a co-branded Medicare drug plan with Humana that steers patients to Walmart stores. The partnership offers a prescription drug plan that can save up to 20 percent in drug costs for customers.
Closer ties between the two companies could allow Walmart to tap into Humana's patient population, expanding low-level medical services in its pharmacies to avoid ER visits. They could allow it to better manage prescription drug use though access to medical records.
Get The News You Want
Humana's biggest business is managing Medicare Advantage health plans for older and disabled people, a heavily regulated business that Walmart would have to take on in an acquisition.
Memberships in retail Medicare Advantage plans - where individuals sign up directly with Humana - rose about 1 percent to 2.86 million, as of Dec. 31. Employer or other group-based Medicare Advantage membership climbed 24 percent to 441,400.
Last month, Walmart reported a sharp drop in profit and online sales growth during the critical holiday period and forecast annual profit at the lower end of expectations.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.